Sex Proportionality in Pre-clinical and Clinical Trials: An Evaluation of 22 Marketing Authorization Application Dossiers Submitted to the European Medicines Agency.

Autor: Dekker MJHJ; Dutch Medicines Evaluation Board, Utrecht, Netherlands., de Vries ST; Dutch Medicines Evaluation Board, Utrecht, Netherlands.; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Centre Groningen, Groningen, Netherlands., Versantvoort CHM; Dutch Medicines Evaluation Board, Utrecht, Netherlands., Drost-van Velze EGE; Dutch Medicines Evaluation Board, Utrecht, Netherlands., Bhatt M; Dutch Medicines Evaluation Board, Utrecht, Netherlands., van Meer PJK; Dutch Medicines Evaluation Board, Utrecht, Netherlands., Havinga IK; Dutch Medicines Evaluation Board, Utrecht, Netherlands., Gispen-de Wied CC; Dutch Medicines Evaluation Board, Utrecht, Netherlands., Mol PGM; Dutch Medicines Evaluation Board, Utrecht, Netherlands.; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Centre Groningen, Groningen, Netherlands.

Publikováno v: Frontiers in medicine [Front Med (Lausanne)] 2021 Mar 11; Vol. 8, pp. 643028. Date of Electronic Publication: 2021 Mar 11 (Print Publication: 2021).